Department of Biomedical Engineering
Friedrich-Alexander-University Erlangen-Nuremberg
Henkestrasse 91, D-91052 Erlangen, Germany
Phone: +49 (0) 9131 85-25630
Fax: +49 (0) 9131 85-25631
e-Mail: bernhard.hensel@fau.de
The Department of Biomedical Engineering is a statutory body
in the Friedrich-Alexander-University Erlangen-Nuremberg.
The statutory representative is Prof. Dr. Bernhard Hensel.
Competent supervisory authority:
Bayerisches Staatsministerium für Wissenschaft, Forschung und Kunst
Editor responsible for the content according to § 6 MDStV:
Prof. Dr. Bernhard Hensel
Copyrights and liability:
The layout of the homepage, the graphics it contains, as well as
the collection of documents are protected by copyright. Reproduction
of these pages is authorized exclusively for personal use, no alterations
are permitted, and any reproduced material may not be disseminated
or displayed in public. All individual documents are likewise protected
by copyright. All information on this server is provided without
guarantee as to its accuracy. Under no circumstances will liability
be assumed for loss or damage sustained through use of the information
provided.
Important note:
Medicine and biomedical engineering are ever-changing sciences undergoing
continual development. Research and clinical experience are continually
expanding our knowledge, in particular our knowledge of proper treatment
and drug therapy. Insofar as this journal mentions any dosage or
application, readers may be confident that the authors, editors,
and publishers have made every effort to ensure that such references
are in accordance with the present state of knowledge at the time
this journal is published. Nevertheless, this does not involve,
imply, or express any guarantee or responsibility on the part of
the publishers in respect to any dosage instructions and forms of
application stated in the journal. Every user is requested to carefully
examine the manufacturer's "Instructions for Use" that
accompany each drug, as well as leaflets accompanying each drug,
and to check, if necessary in consultation with a physician or specialist,
whether the dosage schedules mentioned therein or the contraindications
stated by the manufacturer differ from the statements made in the
present journal. Such examination is particularly important with
drugs that are either rarely used or have been newly released on
the market. Every dosage schedule and every form of application
used is entirely at the user's own risk and responsibility. The
editors and authors request that readers report any discrepancies
or inaccuracies directly to the publishers.
|
|